FEBRUARY 16, 2018

Company

Traws Pharma, Inc.

Filed

February 16, 2018

Accession Number

0001013594-18-000159

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →